Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study.

von Moos R, Body JJ, Guenther O, Terpos E, Acklin YP, Finek J, Pereira J, Maniadakis N, Hechmati G, Talbot S, Sleeboom H.

J Bone Oncol. 2018 Feb 5;10:49-56. doi: 10.1016/j.jbo.2018.01.003. eCollection 2018 Mar.

2.

CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer.

Svobodova S, Kucera R, Fiala O, Marie K, Narsanska A, Zedníková I, Treska V, Slouka D, Milena R, Topolcan O, Finek J.

Anticancer Res. 2018 Jan;38(1):465-469.

PMID:
29277810
3.

Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients.

Poprach A, Fiala O, Chloupkova R, Melichar B, Lakomy R, Petrakova K, Zemanova M, Kopeckova K, Slaby O, Studentova H, Kopecký J, Kiss I, Finek J, Dusek L, Buchler T.

Anticancer Res. 2018 Jan;38(1):449-456.

PMID:
29277808
4.

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry.

Lakomy R, Poprach A, Bortlicek Z, Melichar B, Chloupkova R, Vyzula R, Zemanova M, Kopeckova K, Svoboda M, Slaby O, Kiss I, Studentova H, Juracek J, Fiala O, Kopecky J, Finek J, Dusek L, Hejduk K, Buchler T.

BMC Cancer. 2017 Dec 21;17(1):880. doi: 10.1186/s12885-017-3901-5.

5.

[Immunotherapy in the Treatment of Lung Cancer].

Fiala O, Šorejs O, Pešek M, Fínek J.

Klin Onkol. 2017 Winter;30(Supplementum3):22-31. doi: 10.14735/amko20173S22. Czech.

PMID:
29239189
6.

Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC.

Fiala O, Hosek P, Pesek M, Finek J, Racek J, Stehlik P, Sorejs O, Minarik M, Benesova L, Celer A, Nemcova I, Kucera R, Topolcan O.

Anticancer Res. 2017 Nov;37(11):6469-6476.

PMID:
29061834
7.

[Evaluation of Anti-cancer Therapies with Reimbursement Limited to Comprehensive Cancer Centres Using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale].

Büchler T, Melichar B, Vrána D, Lemstrová R, Fínek J, Dušek L, Petráková K, Prausová J.

Klin Onkol. 2017 Fall;30(5):349-360. doi: 10.14735/amko2017349. Czech.

PMID:
29031037
8.

Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer.

Buchler T, Poprach A, Bortlicek Z, Lakomy R, Chloupková R, Vyzula R, Zemanova M, Kopeckova K, Svoboda M, Slaby O, Kiss I, Studentova H, Hornova J, Fiala O, Kopecky J, Finek J, Dusek L, Melichar B; Czech Metastatic Renal Cancer Cooperative Group.

Clin Genitourin Cancer. 2017 Dec;15(6):e1047-e1053. doi: 10.1016/j.clgc.2017.06.006. Epub 2017 Jun 29.

PMID:
28720439
9.

The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab.

Fiala O, Pitule P, Hosek P, Liska V, Sorejs O, Bruha J, Vycital O, Buchler T, Poprach A, Topolcan O, Finek J.

Tumour Biol. 2017 Jul;39(7):1010428317709283. doi: 10.1177/1010428317709283.

PMID:
28714375
10.

[Breast Cancer in Young Women - Correlation of Clinical Histomorphological, and Molecular-genetic Features of Breast Carcinoma in Women Younger than 35 Years of Age].

Metelková A, Skálová A, Fínek J.

Klin Onkol. Summer 2017;30(3):202-209. doi: 10.14735/amko2017202. Czech.

PMID:
28612617
11.

Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings.

Vojtíšek R, Korčáková E, Mařan J, Šorejs O, Fínek J.

Rep Pract Oncol Radiother. 2017 Jul-Aug;22(4):265-276. doi: 10.1016/j.rpor.2017.02.004. Epub 2017 May 5.

PMID:
28507455
12.

Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic.

Cristino J, Finek J, Jandova P, Kolek M, Pásztor B, Giannopoulou C, Qian Y, Brezina T, Lothgren M.

J Med Econ. 2017 Aug;20(8):799-812. doi: 10.1080/13696998.2017.1328423. Epub 2017 Jun 7.

PMID:
28485692
13.

Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed.

Fiala O, Hosek P, Pesek M, Finek J, Racek J, Buchler T, Poprach A, Hejduk K, Chloupkova R, Sorejs O, Ecksteinova M, Vitovec M, Cizkova K, Kucera R, Topolcan O.

Neoplasma. 2017;64(4):605-610. doi: 10.4149/neo_2017_416.

PMID:
28485168
14.

[Everolimus in Daily Clinical Practice Focusing to Oral Mucosa Damage Issues - Single Oncology Centre Experience within the Course of the Year 2016].

Vokurka S, Votavová M, Arnetová V, Korunková H, Svoboda T, Kulhánková J, Kališová K, Matějka VM, Fiala O, Fínek J.

Klin Onkol. 2017 Spring;30(Supplementum1):195-197. Czech.

PMID:
28471205
15.

Liver Resections for Colorectal Metastases in Patients Aged Over 75 Years.

Treska V, Fichtl J, Bruha J, Liska V, Kormunda S, Finek J.

Anticancer Res. 2017 Mar;37(3):1529-1533.

PMID:
28314329
16.

MIC1/GDF15 as a Bone Metastatic Disease Biomarker.

Windrichova J, Fuchsova R, Kucera R, Topolcan O, Fiala O, Finek J, Slipkova D.

Anticancer Res. 2017 Mar;37(3):1501-1505.

PMID:
28314325
17.

Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy.

Fiala O, Pesek M, Skrickova J, Kolek V, Salajka F, Tomiskova M, Satankova M, Kultan J, Kuliskova J, Svaton M, Hrnciarik M, Hejduk K, Chloupkova R, Topolcan O, Hornychova H, Nova M, Ryska A, Finek J.

Tumour Biol. 2017 Feb;39(2):1010428317691186. doi: 10.1177/1010428317691186.

PMID:
28218046
18.

[Epithelial-mesenchymal Transition in Tumor Tissue and Its Role for Metastatic Spread of Cancer].

Matějka VM, Fínek J, Králíčková M.

Klin Onkol. Winter 2017;30(1):20-27. doi: 10.14735/amko201720. Review. Czech.

PMID:
28185461
19.

Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries.

Body JJ, Acklin YP, Gunther O, Hechmati G, Pereira J, Maniadakis N, Terpos E, Finek J, von Moos R, Talbot S, Sleeboom H.

J Bone Oncol. 2016 Sep 12;5(4):185-193. doi: 10.1016/j.jbo.2016.07.003. eCollection 2016 Nov.

20.

[Radiotherapy Indications in Patients with Hematological Malignancies During the Five Years Course of Modernized Center of Oncology and Radiotherapy Clinic in Pilsen].

Vokurka S, Fínek J, Svoboda T, Vojtíšek R, Votavová M, Havránek K, Salvét J, Šindelářová B, Mařan J, Sukovská E, Vasilev K, Schutzova M, Vozobulová V, Jindra P, Sýkora J.

Klin Onkol. 2016;29(4):313-4. Czech.

PMID:
27534789

Supplemental Content

Loading ...
Support Center